Is XNCR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for XNCR. It does not provide personalized investment advice.

XNCR (Xencor, Inc.) Stock Analysis - Financials

Xencor, Inc. (XNCR) is a publicly traded Healthcare sector company. As of July 8, 2026, XNCR trades at $15.67 with a market cap of $1.10B and a P/E ratio of -6.72. XNCR moved +5.31% today. Year to date, XNCR is +4.26%; over the trailing twelve months it is +97.36%. Its 52-week range spans $6.92 to $27.24. Analyst consensus is strong buy with an average price target of $24.30. Rallies surfaces XNCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are XNCR's key financials?

XNCR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. XNCR recently traded at $15.67. Market cap is $1.10B. P/E ratio is -6.72. Revenue is $97.36M.

XNCR Key Metrics

Key financial metrics for XNCR
Metric	Value
Price	$15.67
Market Cap	$1.10B
P/E Ratio	-6.72
EPS	$-2.29
Dividend Yield	0.00%
52-Week High	$27.24
52-Week Low	$6.92
Volume	591.18K
Avg Volume	0
Revenue (TTM)	$97.36M
Net Income	$-172.42M
Gross Margin	0.00%

XNCR Analyst Consensus

11 analysts cover XNCR: 0 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.30.

Common questions about XNCR

What are XNCR's key financials?: XNCR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. XNCR recently traded at $15.67. Market cap is $1.10B. P/E ratio is -6.72. Revenue is $97.36M.
Is XNCR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for XNCR. It does not provide personalized investment advice.